Predictive factors of severe coronavirus disease 2019 in previously healthy young adults: a single-center, retrospective study

Several previously healthy young adults have developed Coronavirus Disease 2019 (COVID-19), and a few of them progressed to the severe stage. However, the factors are not yet determined. We retrospectively analyzed 123 previously healthy young adults diagnosed with COVID-19 from January to March 202...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory research 2020-06, Vol.21 (1), p.157-157, Article 157
Hauptverfasser: Zhou, Changzhi, Huang, Zhe, Tan, Weijun, Li, Xueying, Yin, Wen, Xiao, Yang, Tao, Zhaowu, Geng, Shuang, Hu, Yi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Several previously healthy young adults have developed Coronavirus Disease 2019 (COVID-19), and a few of them progressed to the severe stage. However, the factors are not yet determined. We retrospectively analyzed 123 previously healthy young adults diagnosed with COVID-19 from January to March 2020 in a tertiary hospital in Wuhan. Patients were classified as having mild or severe COVID-19 based on their respiratory rate, SpO , and PaO /FiO levels. Patients' symptoms, computer tomography (CT) images, preadmission drugs received, and the serum biochemical examination on admission were compared between the mild and severe groups. Significant variables were enrolled into logistic regression model to predict the factors affecting disease severity. A receiver operating characteristic (ROC) curve was applied to validate the predictive value of predictors. Age; temperature; anorexia; and white blood cell count, neutrophil percentage, platelet count, lymphocyte count, C-reactive protein, aspartate transaminase, creatine kinase, albumin, and fibrinogen values were significantly different between patients with mild and severe COVID-19 (P 
ISSN:1465-993X
1465-9921
1465-993X
1465-9921
DOI:10.1186/s12931-020-01412-1